TABLE 3.
KEGG pathway enrichment analysis of DEGs between HSPB8 high expression and low expression groups.
| ID | Description | p.adjust | Qvalue | Count |
|---|---|---|---|---|
| hsa04060 | Cytokine-cytokine receptor interaction | 0.045336 | 0.041118 | 15 |
| hsa04270 | Vascular smooth muscle contraction | 0.000189 | 0.000171 | 14 |
| hsa04510 | Focal adhesion | 0.009932 | 0.009008 | 14 |
| hsa04974 | Protein digestion and absorption | 0.000111 | 0.000101 | 13 |
| hsa05205 | Proteoglycans in cancer | 0.042693 | 0.038721 | 12 |
| hsa04512 | ECM-receptor interaction | 0.009932 | 0.009008 | 9 |
| hsa05150 | Staphylococcus aureus infection | 0.009932 | 0.009008 | 9 |
| hsa05414 | Dilated cardiomyopathy | 0.009932 | 0.009008 | 9 |
| hsa04610 | Complement and coagulation cascades | 0.018281 | 0.01658 | 8 |
| hsa05410 | Hypertrophic cardiomyopathy | 0.023775 | 0.021563 | 8 |
| hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 0.042398 | 0.038453 | 8 |
| hsa05146 | Amoebiasis | 0.042693 | 0.038721 | 8 |
| hsa05219 | Bladder cancer | 0.009932 | 0.009008 | 6 |
| hsa00590 | Arachidonic acid metabolism | 0.042693 | 0.038721 | 6 |